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Abstract—The hypothesis that exposure of a solid tumor to high-energy shock waves (HESW) could lead 
to an increase of metastases was investigated in an animal model. The highly metastatic AT-6 Dunning 
R3327 rat prostate cancer subline was implanted in the hind limb of a Fisher-Copenhagen rat and was 
exposed to 6000 shock waves delivered by an experimental lithotripter, or sham-treated, as soon as the 
tumor had reached a volume of 175-225 mm3. The tumor-bearing leg was amputated 24 h later and the 
number of metastases was examined 12 weeks thereafter at autopsy. Metastases were seen in 82% of the 
animals exposed to HESW and in 25% of the sham-treated animals. There was no significant difference in 
weight of the lungs that contained metastases, between sham and treated animals. These results were 
confirmed in a second experiment. We conclude that the metastatic spread of tumors with a high metastatic 
potential may be enhanced by shock-wave exposure.
Key Words: High-energy shock waves, Metastases, Dunning rat prostate cancer.
INTRODUCTION
Extracorporeally generated focused HESW are clini­
cally used in the noninvasive treatment of most renal 
and ureteral calculi (Chaussy et al. 1980). Several 
other applications of HESW have been reported, such 
as disintegration of salivary gland stones and gall blad­
der stones, treatment of fractures and tumor treatment 
(Cornel et al. 1994a; Iro et al. 1989; Sackman 1988; 
Sauerbruch et al. 1986; Valchanou and Miehailov 
1991 ). in particular, since HESW can be focused into 
a small area of interest within the body, the efficacy of 
HESW as a new experimental noninvasive antitumor 
therapy has been extensively investigated.
Temporary and complete suppression of local tu­
mor growth has been demonstrated in animal models, 
after local administration of HESW (Debus etal. 1991; 
Delius et al. 1989; Hoshi et al. 1991; Oosterhof et al. 
1990b; Russo et al. 1985; Weiss et al. 1990). Further­
more, the combination of HESW and chemotherapy 
or cytokines has been found to produce additive or 
synergistic antitumor effects (Holmes et al. 1990; Lee
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et al. 1990; Oosterhof et al. 1990a, 1991). Until now, 
no severe local or systemic side effects, in particular 
no enhanced risk for metastases, have been seen in 
animal studies (Gamarra et al. 1993; Geldhof et al. 
1989; Holmes et al. 1990; Hoshi et al. 1991; Oosterhof 
et al. 1990a, 1990b, 1991). However, none of these 
studies specifically aimed to examine the potential risk 
of increased metastases after HESW exposure. Before 
HESW will ever become clinically applicable in (uro­
logical) oncology, not only the effective dosage and 
methods of administration have to be established, but 
also the question whether HESW influence the devel­
opment of metastases has to be answered. Since HESW 
cause structural and functional disturbances of the vas­
cular system with necrosis, it is conceivable that expo- 
sure of a tumor to HESW may lead to an increase of 
metastatic spread (Debus et al. 1991; Gamarra et al. 
1993; Hoshi et al. 1991; Oosterhof et al. 1990b; Russo 
et al. 1987; Smits et al. 1991, 1994).
In this study, we therefore wanted to investigate 
this hypothesis more in detail. We used the highly 
metastatic AT-6 Dunning R3327 prostate cancer sub­
line and exposed the tumors at such a volume that 
changes in metastatic rate, after HESW or sham treat­
ment, could easily be detected.
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M E T H O D S
Animals
Adult male FI hybrid rats (F344CopFl/OLA/ 
HSD, Copenhagen male and Fisher female) were pur­
chased from Harlan OLAC (Bicester, England). The 
Fisher-Copenhagen rats were housed three animals per 
cage and subjected to a 12 h cycle of light and darkness. 
They were provided free access to a standard pelleted diet 
(Hope Farms, Woerden, The Netherlands) and acidified 
water (pH 3). The experiments were in accordance with 
institutional and legal requirements.
Tumors
The AT-6 Dunning R-3327 rat prostate cancer sub­
line was established in our own laboratory and has been 
described previously (Bussemakers et al. 1992). In brief, 
AT-6 tumors are anaplastic, hormone nonresponsive and 
highly metastatic to the lungs. AT-6 tumors were excised 
from tumor-bearing rats and, after removal of normal 
and necrotic tissue, 2 0 -25  mg pieces of tumor were 
transplanted subcutaneously in the hind limb of anaesthe­
tized Fisher-Copenhagen rats.
The tumor volume was determined by measuring 
the three dimensions with a precision sliding caliper: 
maximum diameter (L ), width (W)  and height ( / / ) .  No 
corrections were made for skin thickness. The tumor vol­
ume (V)  was calculated from the formula V = t v /6  X L 
X W  X H.  In this study, tumors were allowed to grow 
to a tumor volume of 175-225 mm3. When the tumors 
had reached this desired volume, the rats were randomly 
divided in two groups: one control group (N  = 16 rats) 
and one HESW-exposed group (N  = 17 rats). The exper­
iments were later repeated with 10 animals in each group, 
thus a total of 27 rats were treated with HESW and 26 
animals were sham-treated.
HESW
HESW were generated by an experimental set-up 
of the commercially available electromagnetic shock 
wave source Lithostar Plus (Siemens AG, Erlangen, 
Germany). The physical and technical characteristics 
of this experimental shock-wave source have been de­
scribed earlier (Cornel et al. 1995; Steinbach et al. 
1992). In short, the positive pressures range from 24 
to 63 MPa, the corresponding energy densities, defined 
as the time integral over the duration of a pulse, range 
from 0.08 to 0.6 m l/m m 2, The main frequency of the 
pulse was 200 kHz (resonance frequency of the sys­
tem), but frequencies up to 10 MHz are included. Neg­
ative pressures range from 5 to 10 MPa. The pressure 
rise time, defined as the time for the pressure to rise 
from 10% to 90% of the value of P max, ranged from
30 to 120 ns, respectively. The half-width time, defined 
as the half-amplitude width of the initial positive pres­
sure half cycle was about 5 /us. The pulse-to-pulse 
variation was about 2 -3% . The HESW were focused 
centrally on the tumors. In this way, we ensured that, 
according to pressure measurements, all parts of the 
exposed tumors experienced more than one third of 
the maximal pressure applied centrally. The shock 
waves were applied with a frequency of 2 Hz and 
with an energy density of 0.47 mJ/mm2. Prior to the 
application of HESW, rats were anaesthetized with 30 
mg/kg phenobarbital (Apharma, Arnhem, the Nether­
lands). Hair in the tumor area was removed using a 
depilatory cream (Reckitt and Collman, Naarden, The 
Netherlands). Rats were kept in a fixed position in a 
plastic tube which was placed in the water bath con­
taining degassed water at 37°C. The tumor-bearing leg 
was projected through a hole in the base of the plastic 
tube and the centre of the tumor was positioned in 
the focal area through a three-dimensional positioning 
system. Each HESW administration consisted of, in 
total, 6000 pulses. The rats in the sham-treated group 
were anaesthetized, shaved and positioned in the same 
fixed position, in a water bath containing degassed 
water at 37°C in the same way as the HESW-exposed 
animals but did not receive the HESW exposure.
Surgical procedures
Surgical removal of the primary tumor was per­
formed 24 h after HESW exposure or sham treatment 
according to the technique described by Kadmon et al. 
(1982). In brief, the tumor was removed by disarticu­
lation at the hip joint of the tumor-bearing left hind 
limb. Haemostasis was obtained by using a 3 /0  silk 
ligature on the femoral artery and vein. Additional hae­
mostasis was performed, if needed, by electrocautery. 
The skin incisions were then closed with the use of 
skin clips (7,5 X 1.75 mm, Aesculap, Germany).
Evaluation o f  metastasis rate
All animals were evaluated at 12 weeks postam­
putation or earlier in case of death. At the time of 
killing or death, a complete autopsy was performed. 
Rats were carefully examined macroscopically for me- 
tastases in lymph nodes and visceral organs ( in particu­
lar the lungs). The lungs of all rats were excised, 
weighed and the total number of metastases was mac­
roscopically counted. The lungs were then fixed in 
buffered 4% formalin and 4 /zm sections were cut and 
stained with haematoxylin and eosin. All lungs were 
microscopically examined to confirm the macroscopi­
cally visible metastases and to rule out micro metas­
tases in the lungs that macroscopically were not visible.
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Table 1. Results of first experiment. Tumor volume (mm3) 
and weight of lungs (g) are given in mean values with
standard deviations in parentheses.
Sham HESW Significance
Number of treated rats 16 17
Tumor volume (SD) 204 (19) 197 (17) p =  0.45
at time of exposure
p  =  0.001Number of rats with 4 (25%) 14 (82%)
metastases at killing
(%)
Weight of lungs (SD) 2.4 ( 1.6) 3.9 (4.8) p =  0.55
of rats with
metastases at killing
to necrosis of the tumor (Debus et al. 1991; Hoshi et al. 
1991; Oosterhof et al. 1990b; Russo et al. 1987). Evalua­
tion of HESW-exposed tumors with nuclear magnetic 
resonance spectroscopy revealed a significant temporary 
dose-dependent acidification and depletion of energy-rich 
metabolites of the tumor (Smits et al. 1991, 1994). Fur­
thermore, several investigators have shown that HESW 
exposure of tumors leads to a temporary impairment of 
tumor blood flow (Gamarra et al. 1993; Smits et al. 
1991, 1994). Recently, a threefold local increase in the 
concentration of a systemically given drug has been 
found after the local administration of HESW, related to 
a temporary impairment of the tumor blood flow (Gomel 
et al. 1994b).
Metastasis formation is a process of linked se­
quential steps (Fidler 1991). One of the major steps is 
embolisation of tumor cells in the bloodstream. Weiss 
(1990) demonstrated that development of necrotic and 
haemorrhagic areas facilitates entry of cells in the cir­
culation. HESW  exposure leads to structural and func­
tional disturbances of the vascular system with necrosis 
(Debus et al. 1991; Gamarra et al. 1993; Hoshi et ah 
1991; Oosterhof et al. 1990b; Russo et al. 1987; Smits 
et al. 1991, 1994). Embolisation of (non)viable tumor 
cells may thus be facilitated by HESW. Fidler (1970) 
demonstrated that, although tumor cells are quickly 
destroyed within the bloodstream, the greater the num­
ber of cells released by the primary tumor, the greater 
the chance that tumor cells will survive and form me- 
tastases. Moreover, Young and Hill (1990) found that 
when tumor cells are reoxygenized after a period of 
acute hypoxia they have a 1 .5 -3  times increased meta­
static ability compared to aerobic cells. Our group has 
shown that HESW  tumor exposure induces a period 
of acute hypoxia by a temporarily decreased tumor 
blood flow (Cornel et al. 1995; Smits et al. 1994). 
Therefore, it is conceivable that exposure of a tumor 
to HESW leads to an increase of metastatic spread 
due to the liberation of tumor cells and transient acute
hypoxia. Animal studies carried out so far have never 
shown severe local or systemic complications (e.g., 
induction or enhancement of metastases), after the lo­
cal HESW administration on tumors. Geldhof et al. 
(1989) used the highly metastatic MatLyLu rat pros­
tate cancer Dunning subline to address the issue of 
whether HESW affect the metastatic spread and no 
relation could be seen. Also Hoshi et aL (1991) found 
no effects on metastasis formation in a HESW-sensi­
tive rabbit bladder cancer model. In earlier studies, 
we described HESW administration in several tumor 
model systems with different biological behaviour and 
induction or enhancement of metastases was never 
seen (Oosterhof et al. 1990a, 1990b, 1991). Although 
all these aforementioned studies did not demonstrate 
enhancement or induction of metastases after HESW 
administration, the results should be interpreted criti­
cally for several reasons. First, some of the tumor mod­
els used have never shown any metastatic potential 
and it is therefore questionable whether such a tumor 
is appropriate for evaluating the influence of HESW 
on metastasis formation. Second, potentially metasta- 
sising tumors should be exposed to HESW in the early 
phase of the metastasising process to be able to quan­
tify the size and number of (lung) metastases. Third, 
only tumors that metastasise to only one organ should 
be used to assure that all metastases are taken into 
account.
For our study we choose the Dunning rat prostate 
tumor subline, AT-6, that is highly metastatic to the 
lungs (Bussemakers et al. 1992). Henry and Isaacs 
(1988) demonstrated a relationship between tumor size 
and number of lung metastases in another highly me­
tastasising Dunning subline: the larger the parental tu­
mor the higher the number of established lung metasta­
ses. Moreover, their results demonstrated that the meta­
static deposits are not established immediately after 
inoculation of the tumor but occur only after the pri­
mary tumor has undergone a critical growth period.
Table 2. Results of second experiment. Tumor volume 
(mm3) and weight of lungs (g) are given in mean values
with standard deviations in parentheses.
Sham HESW Significance
Number of treated rats 10 10
Tumor volume (SD) at 199 (29) 191 (17) p = 0.47
time of exposure
Number of rats with 0 (0%) 6 (60%) p = 0.003
metastases at killing
(%)
Weight of lungs (SD) Not done 4.3 (5.1)
of rats with
metastases at killing
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Table 3. Results o f  sham or H ESW  treatment in each 
animal in both experiments: developm ent o f  métastasés, 
number o f  métastasés and weight o f the lungs (grams).
Animal (number) 
in control group
Lung 
métastasés 
(y es/no)
Number of 
métastasés
Weight of 
lungs 
(g)
First experiment 
1 yes 1 1.6012
2 no 0 1.2153
3 no 0 1.3285
4 no 0 1.3077
5 yes 1 1.4090
6 yes 1 1.7236
7 no 0 1.3602
8 no 0 1.4017
9 yes 17 4.7935
10 no 0 1.2099
11 no 0 1.4603
12 no 0 1.3497
13 no 0 1.4217
14 no 0 1.2067
15 no 0 1.4187
16 no 0 1.6576
HESW-treated
1 no 0 1.4402
2 yes 19 7.6895
3 yes 2 1.7954
4 no 0 1.4783
5 no 0 1.2463
6 yes 1 1.6648
7 yes 1 1.2264
8 yes 17 4.6705
9 yes 2 2.5526
10 yes 1 1.3853
11 yes 5 2.2734
12 yes 7 2.5944
13 yes 3 2.2759
14 yes 1 1.5807
15 yes 79 19.4185
16 yes 1 1.2401
17 yes 8 . 4.2004
Second experiment
1 no 0 1.4677
2 no 0 1.5710
3 no 0 1.4932
4 no 0 1.4903
5 no 0 1.4336
6 no 0 1.4250
7 no 0 1.4301
8 no 0 1.3450
9 no 0 1.4830
10 110 0 1.4230
HESW-treated
1 yes 1 1.5630
2 yes 1 1.3337
3 no 0 1.4982
4 yes 52 17.0791
5 yes 1 1.7673
6 no 0 1.3900
7 no 0 1.4565
8 no 0 1.4871
9 yes 17 7.5542
10 yes 2 2.1951
This “ window” was also determined for the highly 
metastatic AT-6 used in our study. A pilot study re­
vealed that tumors with a volume of 200 mm3 had led 
to métastasés in 40%, whereas in tumors greater in 
size than 400 mm3 métastasés were present in 100%.
AT-6 tumors were transplanted in such a way on 
the hind limb of F isher-Copenhagen rats that the tu­
mor and the implantation “ area”  could be removed 
completely by disarticulation of the tumor-bearing leg. 
By doing so we did not encounter any local recurrence 
after amputation, neither in the sham nor in the HESW- 
exposed group.
Tumors were sham treated or exposed to 6000 
HESW at a tumor volume of 200 mm3. The tumor- 
bearing legs were removed 24 h after sham or HESW 
treatment. The only variable between the two groups 
was HESW administration. Differences in metastatic rate, 
evaluated 12 weeks postamputation, can therefore only 
be related to the HESW exposure. Our results clearly 
demonstrate a statistically significant enhancement of mé­
tastasés after HESW exposure. A total of 82% of the rats 
in the HESW-exposed group had métastasés, compared 
with 25% of the rats in the sham-exposed group. This 
60% higher metastasis rate in the HESW-exposed group 
was confirmed in a second experiment. As indicated be­
fore, embolisation of tumor cells by HESW and hypoxia, 
leading to an increased metastatic capacity, may explain 
this adverse effect of HESW.
We conclude that, although tumor treatment with 
HESW results in growth-suppressive effects, the in­
creased risk for métastasés obstructs the clinical appli­
cation of HESW as a new antitumor modality.
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